NASDAQ$ZURA

Zura Bio Limited · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Headline financials

EPS (adj)

-$2.76

Previous: -$72.4K+100.0%
Net Income

-$9.59M

Previous: -$7.82M-22.7%
Operating Income

-$7.72M

Previous: -$7.82M+1.3%
Cash & Equivalents

$44M

Previous: $515K+8450.3%
Total Assets

$44.4M

Previous: $140M-68.4%
Stock-Based Comp

$180K

No prior period

Revenue & EPS history

Zura Bio · Revenue · Quarterly

$0

Q4 2025

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 10 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

-1.2%

Avg return

Earnings day

-2.4%

Avg return

5 days after

-3.1%

Avg return

30 days after

36%

4 / 11 earnings

Positive

+22.8%

Q4 2023

Best reaction

-26.0%

Q1 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-3.2%-2.9%-30.5%
Q4 2025-9.5%-17.3%-13.2%
Q2 2025+6.9%+8.8%+25.8%
Q1 2025-7.6%-14.2%+0.0%
Q4 2024+4.0%+5.3%-33.0%
Q1 2024-0.6%+9.6%-14.9%
Q4 2023+22.8%+26.3%+90.1%
Q3 2023+2.8%-1.2%-4.2%
Q2 2023-0.6%-1.2%+1.8%
Q1 2023-26.0%-28.5%-3.0%
Q4 2022-1.8%-11.4%-52.5%
Q3 2022
Q2 2022
Q1 2022

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro